|Datasheet||Specific References||Reviews||Related Products||Protocols|
|ORF Clone of Homo sapiens nucleophosmin (nucleolar phosphoprotein B23, numatrin) DNA.|
|Identical with the Gene Bank Ref. ID sequence.|
|Whatman FTA elute card (Cat: WB120410) contains 5-10 μg of plasmid.|
|The Whatman FTA elute card can be stored at room temperature for three months under dry condition.|
The pGEM-T is 3kb in length, and contains the amplicin resistance gene, conferring selection of the plasmid in E. coli, and the ori site which is the bacterial origin of replication. The plasmid has multiple cloning sites as shown below. The coding sequence was inserted by TA cloning. Many E. coli strains are suitable for the propagation of this vector including JM109, DH5α and TOP10.
The coding sequence can be easily obtained by digesting the vector with proper restriction enzyme(s). The coding sequence can also be amplified by PCR with M13 primers, or primer pair SP6 and T7.
|Human NPM1 Gene cDNA Clone (full-length ORF Clone), expression ready, FLAG-tagged||HG12074-G-F|
|Human NPM1 Gene cDNA Clone (full-length ORF Clone), expression ready, His-tagged||HG12074-G-H|
|Human NPM1 Gene cDNA Clone (full-length ORF Clone), expression ready, Myc-tagged||HG12074-G-M|
|Human NPM1 Gene cDNA Clone (full-length ORF Clone), expression ready, untagged||HG12074-G-N|
|Human NPM1 Gene cDNA Clone (full-length ORF Clone), expression ready, HA-tagged||HG12074-G-Y|
|Product name||Product name|
Nucleophosmin 1 (NPM1), also known as nucleolar phosphoprotein B23 or numatrin, is a member of the nucleoplasmin family. Nucleophosmin (NPM) is a nucleolar phosphoprotein that plays multiple roles in ribosome assembly and transport, cytoplasmic-nuclear trafficking, centrosome duplication and regulation of p53. The NPM1 gene is frequently involved in chromosomal translocation, mutation and deletion. Mutations of the NPM1 gene leading to the expression of a cytoplasmic mutant protein, NPMc+, are the most frequent genetic abnormalities found in acute myeloid leukemias. Acute myeloid leukemias (AML) with mutated NPM1 have distinct characteristics, including a significant association with a normal karyotype, involvement of different hematopoietic lineages, a specific gene-expression profile and clinically, a better response to induction therapy and a favorable prognosis. In addition, NPM1 is a crucial gene to consider in the context of the genetics and biology of cancer. NPM1 is frequently overexpressed, mutated, rearranged and deleted in human cancer. Traditionally regarded as a tumour marker and a putative proto-oncogene, it has now also been attributed with tumour-suppressor functions.